Cancer Care Ontario | Cancer Care Ontario

261 Results

Regimen

ANASPALB

Cancer Type:

Breast

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Funding:

ODB - General Benefit

anastrozole

Exceptional Access Program

palbociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, according to clinical criteria

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

anastrozole,

palbociclib

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Apr 2024

Document

[PDF]

AC-PACL(DD) Patient Info Sheet

Apr 2019

Abnormal Fecal Immunochemical Test (FIT) Result Frequently Asked Questions

If you got a letter from ColonCancerCheck with an abnormal fecal immunochemical test (FIT) result, the information on this page can help you...

Guidelines and Advice

Autologous hematopoietic cell transplantation for autoimmune diseases

Status: Current
ID: ES SCT-10

May 2019

Questions fréquemment posées sur les résultats anormaux au test immunochimique fécal (TIF)

Si vous avez reçu une lettre de ContrôleCancerColorectal avec des résultats anormaux au test immunochimique fécal (TIF), l’information sur cette page...

Regimen